Burning mouth syndrome: diagnostic appraisal and management strategies (original) (raw)

Abstract

Sukumaran Anil, BDS, MDS, PhD, FICD, FPFA, Mohammed Nasser Alsqah, BDS, R. Rajendran, BDS, MDS, PhD College of Dentistry, King Saud University, Riyadh Burning Mouth Syndrome: Diagnostic appraisal and management strategies Abstract Burning mouth syndrome (BMS) is a disorder that is characterized by a burning sensation of the oral cavity in the absence of visible local or systemic abnormalities. Affected patients often present with multiple oral complaints, including burning, dryness and taste alterations. The exact cause of burning mouth syndrome often is difficult to pinpoint. Conditions that have been reported in association with burning mouth syndrome include chronic anxiety or depression, various nutritional deficiencies, type 2 diabetes and changes in salivary function. Studies have pointed to dysfunction of the cranial nerves associated with taste sensation as a possible cause of burning mouth syndrome. Since burning mouth symptoms may arise as the result of a number of etiologic factors, diagnosis and management of the patient with BMS should involve consideration of all possible causative factors. Hormone replacement therapy, benzodiazepines/ anti-convulsants, anti-depressants, analgesics, capsaicin, alpha-lipoic acid and cognitive behavioral therapy etc. have all been used in the management of BMS. The present review outlines various aspects of BMS, updates current knowledge on the disease, and provides guidelines for successful patient management.

Figures (2)

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (65)

  1. Classification of chronic pain: descriptions of chronic pain syn-dromes and definitions of pain terms. Task Force on Taxonomy of the International Association for the Study of Pain; 1994; Seattle. IASP.
  2. Grinspan D, Fernandez Blanco G, Allevato MA, Stengel FM. Burning mouth syndrome. Int J Dermatol 1995;34(7):483- 487.
  3. Woda A, Navez ML, Picard P, Gremeau C, Pichard-Leandri E. A possible therapeutic solution for stomatodynia (burning mouth syndrome). J Orofac Pain 1998;12(4):272- 278.
  4. Brown RS, Krakow AM, Douglas T, Choksi SK. "Scalded mouth syndrome" caused by angiotensin converting enzyme inhibitors: two case reports. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83(6):665- 667.
  5. Zakrzewska JM. The burning mouth syndrome remains an enigma. Pain 1995;62(3):253-257.
  6. Ship JA, Grushka M, Lipton JA, Mott AE, Sessle BJ, Dionne RA. Burning mouth syndrome: an update. J Am Dent Assoc 1995;126(7):842-853.
  7. Ben Aryeh H, Gottlieb I, Ish-Shalom S, David A, Szargel H, Laufer D. Oral complaints related to menopause. Maturitas 1996;24(3):185-189.
  8. Klausner JJ. Epidemiology of chronic facial pain: diagnostic usefulness in patient care. J Am Dent Assoc 1994;125(12):1604- 1611.
  9. Maresky LS, Gird I, van der Bijl P. Burning mouth syndrome: a selective review. Ann Dent 1993;52(1):21-25.
  10. Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987;63(1):30-36.
  11. Gorsky M, Silverman S, Jr., Chinn H. Burning mouth syndrome: a review of 98 cases. J Oral Med 1987;42(1):7-9.
  12. Van der Waal I, editor. The burning mouth syndrome. Copenhagen: Munksgaard, 1990.
  13. Main DM, Basker RM. Patients complaining of a burning mouth. Further experience in clinical assessment and management. Br Dent J 1983;154(7):206-211.
  14. Svensson P, Kaaber S. General health factors and denture function in patients with burning mouth syndrome and matched control subjects. J Oral Rehabil 1995;22(12):887-895.
  15. Ali A, Bates JF, Reynolds AJ, Walker DM. The burning mouth sensation related to the wearing of acrylic dentures: an investigation. Br Dent J 1986;161(12):444- 447.
  16. Kaaber S, Thulin H, Nielsen E. Skin sensitivity to denture base materials in the burning mouth syndrome. Contact Dermatitis 1979;5(2):90-96.
  17. Helton J, Storrs F. The burning mouth syndrome: lack of a role for contact urticaria and contact dermatitis. J Am Acad Dermatol 1994;31(2 Pt 1):201-205.
  18. Bergdahl BJ, Anneroth G, Anneroth I. Clinical study of patients with burning mouth. Scand J Dent Res 1994;102(5):299- 305.
  19. Eisen D, Eisenberg E. Oral lichen planus and the burning mouth syndrome. Is there a role for patch testing? Am J Contact Dermat 2000;11(2):111-114.
  20. Zachariasen RD. Oral manifestations of menopause. Compendium 1993;14(12):1584, 1586-1591; quiz 1592.
  21. Basker RM, Sturdee DW, Davenport JC. Patients with burning mouths. A clinical investigation of causative factors, including the climacteric and diabetes. Br Dent J 1978;145(1):9-16.
  22. Pisanty S, Rafaely B, Polishuk W. The effect of steroid hormones on buccal mucosa of menopausal women. Oral Surg Oral Med Oral Pathol 1975;40(3):346-353.
  23. Ferguson MM, Carter J, Boyle P, Hart DM, Lindsay R. Oral complaints related to climacteric symptoms in oophorectomized women. J R Soc Med 1981;74(7):492- 498.
  24. Forabosco A, Criscuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S, et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 1992;73(5):570-574.
  25. Lamey PJ, Hammond A, Allam BF, McIntosh WB. Vitamin status of patients with burning mouth syndrome and the response to replacement therapy. Br Dent J 1986;160(3):81-84.
  26. Hugoson A, Thorstensson B. Vitamin B status and response to replacement therapy in patients with burning mouth syndrome. Acta Odontol Scand 1991;49(6):367-375.
  27. Gallager FJ, Baxter DL, Denobile J, Taybos GM. Glossodynia, iron deficiency anemia, and gastrointestinal malignancy. Report of a case. Oral Surg Oral Med Oral Pathol 1988;65(1):130-133.
  28. Gibson J, Lamey PJ, Lewis M, Frier B. Oral manifestations of previously undiagnosed non-insulin dependent diabetes mellitus. J Oral Pathol Med 1990;19(6):284-287.
  29. Grushka M, Sessle BJ, Miller R. Pain and personality profiles in burning mouth syndrome. Pain 1987;28(2):155-167.
  30. Browning S, Hislop S, Scully C, Shirlaw P. The association between burning mouth syndrome and psychosocial disorders. Oral Surg Oral Med Oral Pathol 1987;64(2):171-174.
  31. Lamb AB, Lamey PJ, Reeve PE. Burning mouth syndrome: psychological aspects. Br Dent J 1988;165(7):256-260.
  32. Rojo L, Silvestre FJ, Bagan JV, De Vicente T. Psychiatric morbidity in burning mouth syndrome. Psychiatric interview versus depression and anxiety scales. Oral Surg Oral Med Oral Pathol 1993;75(3):308- 311.
  33. Gorsky M, Silverman S, Jr., Chinn H. Clinical characteristics and management outcome in the burning mouth syndrome. An open study of 130 patients. Oral Surg Oral Med Oral Pathol 1991;72(2):192- 195.
  34. Glass BJ. Drug-induced xerostomia as a cause of glossodynia. Ear Nose Throat J 1989;68(10):776, 779-781.
  35. Rhodus NL. Xerostomia and glossodynia in patients with autoimmune disorders. Ear Nose Throat J 1989;68(10):791-794.
  36. Soares MS, Chimenos-Kustner E, Subira- Pifarre C, Rodriguez de Rivera-Campillo ME, Lopez-Lopez J. Association of burning mouth syndrome with xerostomia and medicines. Med Oral Patol Oral Cir Bucal 2005;10(4):301-308.
  37. Bartoshuk LM, Snyder DJ, Grushka M, Berger AM, Duffy VB, Kveton JF. Taste damage: previously unsuspected consequences. Chem Senses 2005;30 Suppl 1:i218-i219.
  38. Hershkovich O, Nagler RM. Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances. Arch Oral Biol 2004;49(7):515-522.
  39. Grushka M, Ching V, Epstein J. Burning mouth syndrome. Adv Otorhinolaryngol 2006;63:278-287.
  40. Huang W, Rothe MJ, Grant-Kels JM. The burning mouth syndrome. J Am Acad Dermatol 1996;34(1):91-98.
  41. Botha PJ, van der Bijl P, van Eyk AD. A literature review and pilot study to characterise the treatment of burning mouth syndrome. Sadj 2001;56(8):353- 358.
  42. Zakrzewska JM, Glenny AM, Forssell H. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2001(3):CD002779.
  43. Tourne LP, Fricton JR. Burning mouth syndrome. Critical review and proposed clinical management. Oral Surg Oral Med Oral Pathol 1992;74(2):158-167.
  44. Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry 2002;63(1):38-43.
  45. Grushka M, Epstein J, Mott A. An open- label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86(5):557-561.
  46. Epstein JB, Marcoe JH. Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994;77(2):135-140.
  47. Savino LB, Haushalter NM. Lisinopril- induced "scalded mouth syndrome". Ann Pharmacother 1992;26(11):1381-1382.
  48. Culhane NS, Hodle AD. Burning mouth syndrome after taking clonazepam. Ann Pharmacother 2001;35(7-8):874-876.
  49. Lamey PJ, Murray BM, Eddie SA, Freeman RE. The secretion of parotid saliva as stimulated by 10% citric acid is not related to precipitating factors in burning mouth syndrome. J Oral Pathol Med 2001;30(2):121-124.
  50. Bergdahl J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med 1995;24(5):213-215. BURNING MOUTH SYNDROME
  51. Jensen JL, Barkvoll P. Clinical implications of the dry mouth. Oral mucosal diseases. Ann N Y Acad Sci 1998;842:156-162.
  52. Niedermeier W, Huber M, Fischer D, Beier K, Muller N, Schuler R, et al. Significance of saliva for the denture-wearing population. Gerodontology 2000;17(2):104-118.
  53. Johansson G, Birkhed D. Effect of a long-term change from a mixed to a lactovegetarian diet on human saliva. Arch Oral Biol 1994;39(4):283-288.
  54. Glaros AG, Forbes M, Shanker J, Glass EG. Effect of parafunctional clenching on temporomandibular disorder pain and proprioceptive awareness. Cranio 2000;18(3):198-204.
  55. Palla S. Molecular biology, tissue engineering, and the future of dentistry. J Orofac Pain 2001;15(4):273-274.
  56. Femiano F, Gombos F, Scully C, Busciolano M, De Luca P. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000;6(5):274- 277.
  57. Femiano F, Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002;31(5):267- 269.
  58. Tirosh O, Sen CK, Roy S, Kobayashi MS, Packer L. Neuroprotective effects of alpha- lipoic acid and its positively charged amide analogue. Free Radic Biol Med 1999;26(11-12):1418-1426.
  59. Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Moller W. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double- blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res 1999;31(3):171-179.
  60. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain 1987;31(2):199-209.
  61. Tammiala-Salonen T, Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain 1999;13(2):83-88.
  62. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003;14(4):275-291.
  63. Scardina GA, Carini F, Valenza V, Messina P. Topical capsaicin application and axon reflex vasodilatation of the tongue: neurogenic involvement in burning mouth syndrome. Methods Find Exp Clin Pharmacol 2006;28(10):707-711.
  64. Humphris GM, Longman LP, Field EA. Cognitive-behavioural therapy for idiopathic burning mouth syndrome: a report of two cases. Br Dent J 1996;181(6):204-208.
  65. Van Houdenhove B, Joostens P. Burning mouth syndrome. Successful treatment with combined psychotherapy and psychopharmacotherapy. Gen Hosp Psychiatry 1995;17(5):385-388.